-
In a prospective, randomized trial, both norethindrone 1 mg/ethinyl estradiol 35 mg taken three times a day initially as well as medroxyprogesterone acetate 20 mg t.i.d. initially were comparably effective and reasonably well tolerated.
-
Despite the grim statistics, recurrent ovarian cancer is somewhat distinguished from other solid tumors in its ability to retain and regain some "sensitivity" to chemotherapy long into its natural progression.
-
New Hope for Macular Degeneration?; Can Cialis be Used for Edema?; FDA Actions
-
For years clinicians have been administering oxygen by mask to patients with worrisome fetal heart rate patterns. Yet, a Cochrane database review has questioned this practice because of the lack of solid date to demonstrate its benefit.
-
The role of primary tumor resection for those who present with disseminated breast cancer has not been established. Rapiti and colleagues performed a population-based study to determine the impact of local surgery on survival in women with breast cancer who, at the time of initial presentation, were known to have distant metastases.
-
-
-
Intrauterine contraception is highly convenient. It provides long-term protection against pregnancy, and the method is promptly reversible. Where does it fit in your facility's cafeteria of options?
-
Will you change your prescribing practice with the Food and Drug Administration's (FDA) recent approval of over the counter (OTC) status for the emergency contraceptive Plan B?
-
The contraceptive vaginal ring (NuvaRing, Organon; West Orange, NJ) and the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical; Raritan, NJ) have become standard options at many facilities since both were approved by the Food and Drug Administration (FDA) in 2001.
